Combination Oral Chelation in Adult Patients With Transfusion-dependent Thalassemia and High Iron Burden

被引：9
|
作者：
Hammond, John [1 ]
Thompson, Alexis A. [4 ,5 ]
Fogel, Mark A. [2 ]
Hammond, Katherine [4 ]
Kokroko, Jolene [1 ]
Kwiatkowski, Janet L. [1 ,3 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Cardiol, 34th St & Civic Ctr Blvd, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2019年 / 41卷 / 01期
关键词：
thalassemia; iron overload; deferasirox; deferiprone; MYOCARDIAL IRON; DEFERIPRONE THERAPY; DEFERASIROX; SAFETY; DEFEROXAMINE; TRIAL; RISK;
D O I：
10.1097/MPH.0000000000001269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
An open-label, pilot study was conducted to evaluate deferasirox/deferiprone combination chelation therapy in adult patients with transfusion-dependent thalassemia and severe iron overload. Enrollment proved difficult. Nine patients (median age, 27.4 y; ferritin, 4965 ng/mL; liver iron concentration, 28.5 mg/g dry weight; cardiac T2*, 13.3 ms) received treatment. Two were withdrawn for treatment-related adverse effects. Arthralgia (4 patients) and gastrointestinal symptoms (5 patients) were common; no episodes of neutropenia/agranulocytosis occurred. Adherence difficulties were common. Of 6 patients with 12 to 18 months follow-up, 3 showed improvement in cardiac T2* and 2 in liver iron. Combination oral chelation may be effective but adverse effects and adherence challenges may limit efficacy.
引用
收藏
页码：E47 / E50
页数：4
相关论文
共 50 条
  • [31] Endocrinopathies in patients with transfusion-dependent ß-thalassemia
    Mehrvar, A.
    Azarkeivan, A.
    Faranoush, M.
    Mehrvar, N.
    Saberinedjad, J.
    Ghorbani, R.
    Vossough, P.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2008, 25 (03) : 187 - 194
  • [32] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia
    Nicholas G. Angelopoulos
    Anastasia Goula
    Grigorios Rombopoulos
    Victoria Kaltzidou
    Eugenia Katounda
    Dimitrios Kaltsas
    George Tolis
    Journal of Bone and Mineral Metabolism, 2006, 24 : 138 - 145
  • [33] Beyond blood transfusions: exploring iron chelation therapies in transfusion-dependent beta-thalassemia
    Talha, Muhammad
    Ali, Mohammad Haris
    Hurjkaliani, Sonia
    Rahmat, Zainab Syyeda
    Sadia, Haleema
    Al Hasibuzzaman, Md.
    Uzair, Ahsan Ul Qayyum
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (01): : 13 - 17
  • [34] Geographical Differences In Transfusion and Iron Chelation Practices In 1558 Patients with Transfusion-Dependent Anemias
    Viprakasit, Vip
    Gattermann, Norbert
    Lee, Jong Wook
    Porter, John B.
    Taher, Ali
    Habr, Dany
    Roubert, Bernard
    Domokos, Gabor
    Cappellini, Maria Domenica
    BLOOD, 2010, 116 (21) : 1733 - 1734
  • [35] Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia
    Origa, Raffaella
    Tatti, Federica
    Zappu, Antonietta
    Leoni, Giovan Battista
    Dessi, Carlo
    Moi, Paolo
    Morittu, Maddalena
    Orecchia, Valeria
    Denotti, Anna Rita
    Pilia, Maria Paola
    Anni, Franco
    Perra, Maria
    Casini, Maria Rosaria
    Barella, Susanna
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : E627 - E628
  • [36] Rapid iron loading in a pregnant woman with transfusion-dependent thalassemia after brief cessation of iron chelation therapy
    Farmaki, Kallistheni
    Gotsis, Efstathios
    Tzoumari, Ioanna
    Berdoukas, Vasilios
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (02) : 157 - 159
  • [37] Iron Chelation in Patients with Transfusion Dependent Thalassemia: An Insight on Response to Deferasirox
    Shaikh, Muhammad Shariq
    Adil, Salman Naseem
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2015, 25 (07): : 553 - 554
  • [38] Therapeutic mechanism of combined oral chelation therapy to maximize efficacy of iron removal in transfusion-dependent thalassemia major - a pilot study
    Lin, Chien-Heng
    Chen, Xianxiu
    Wu, Chin-Ching
    Wu, Kang-Hsi
    Song, Ta-Shu
    Weng, Te-Fu
    Hsieh, Yow-Wen
    Peng, Ching-Tien
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (04) : 265 - 272
  • [39] Pulmonary Dysfunction in Transfusion-Dependent Thalassemia and Response to Intensive Chelation Therapy
    Panwar, Neha
    Gomber, Sunil
    Dewan, Pooja
    Kumar, Raj
    INDIAN PEDIATRICS, 2022, 59 (06) : 451 - 454
  • [40] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
12345